Aptose Biosciences proceeds from closing of public offering Jan 30 $9.7M

On January 30, Aptose closed a public offering of 5,649,122 common shares of the Company and warrants at a combined offering price of $1.71 per share. This included 736,842 Common Shares and warrants pursuant to a full exercise by the underwriter of its over-allotment option. Total gross proceeds from the public offering were approximately $9.7M before deducting underwriting costs, placement agent commissions and other offering-related expenses.